Latest news from SABCS 2025
-
Plenary lecture to explore how patients have become partners in scientific progress
Barbara Segarra-Vazquez, DHSc, and Dennis Slamon, MD, PhD, will discuss how patients and patient advocates have steadily expanded their roles in clinical trial design, drug development and approvals, and other research processes.
-
Plenary lecture to highlight new insights into BRCA1/2-mediated tumorigenesis
Joan Brugge, PhD, will review findings that provide new understanding about the role of chromosomal alterations in breast cancer development.
-
Special session to feature insights into alcohol use and breast cancer risk
Seema A. Khan, MD, will moderate a special session at SABCS 2025 on how alcohol consumption and obesity impact breast cancer risk, and how lifestyle changes may reduce risk.
-
Special session to offer updates on lobular breast cancer
Steffi Oesterreich, PhD, will co-moderate a special session at SABCS 2025 that will highlight lobular breast cancer subtype classification, biomarkers, therapeutic targets, and more.
-
Special session to explore biology, treatment of breast cancer in young women
Ann Partridge, MD, MPH, will moderate a special session at SABCS 2025 that will focus on the unique biological and social circumstances of younger women with breast cancer.
-
Panelists to highlight real-world AI implementations, considerations
Frederick Howard, MD, will moderate an SABCS 2025 educational session that will chart the roadmap of AI in breast cancer — where it is currently, which direction it might be going, and what tools should be used to evaluate its contributions.
-
SABCS 2025 to highlight dynamic landscape of liquid biopsy
Sessions at the 48th annual San Antonio Breast Cancer Symposium will explore the current applications of and questions around liquid biopsy in breast cancer, as well as what’s on the horizon for circulating tumor DNA (ctDNA) and how it might influence future clinical trials.
